Doxazosin Tablet
Product Images NDC 68382-786

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 68382-786). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxazosin Tablets, Usp (A308818e E36c 4431 Bf51 274650c38cb0 01)

Chemical structure of the active ingredient Doxazosin shown as a molecular diagram including aromatic rings, nitrogen atoms, oxygen atoms, and attached functional groups, labeled with the methanesulfonic acid (CH3SO3H) component.*

FDA Label Image

Doxazosin Tablets (A308818e E36c 4431 Bf51 274650c38cb0 02)

A bar chart and table showing the effects of Doxazosin on symptom score and maximum flow rate in three studies with doses up to 8 mg. The table compares baseline and change means for placebo and Doxazosin at various doses, while the bar chart illustrates maximum flow rate changes in Study 2, highlighting greater improvements with 4 mg and 8 mg doses compared to placebo.*

FDA Label Image

Doxazosin Tablets, Usp (A308818e E36c 4431 Bf51 274650c38cb0 03)

Two line graphs illustrating clinical study results for Doxazosin versus placebo. The left graph shows mean change in total symptom score over 14 weeks, with Doxazosin showing a greater decrease compared to placebo. The right graph depicts mean increase in maximum urinary flow rate over the same period, with Doxazosin showing a higher increase versus placebo. Both graphs include error bars and sample sizes (N=50 for Doxazosin, N=47 for placebo).*

FDA Label Image

Container Label 1 mg (100s count)

Label for Doxazosin Tablets, USP 1 mg by Zydus Pharmaceuticals USA Inc. The label shows the product name, strength, a photo of a round tablet engraved with "763", and quantity of 100 tablets. It includes dosage information, storage instructions, manufacturer details, and an NDC number 68382-783-01.*

FDA Label Image

Container Label 2 mg- 100s Count (A308818e E36c 4431 Bf51 274650c38cb0 05)

Doxazosin Tablets, USP 2 mg oral tablet label from Zydus Pharmaceuticals USA Inc. The label shows the product name and strength, an image of round brown tablets engraved with '7B4,' quantity of 100 tablets, and prescription-only status. It includes storage instructions, dosage form, manufacturer (Cadila Healthcare Ltd.), and distributor information.*

FDA Label Image

Container Label 4 mg (100s count)

Doxazosin Tablets USP 4 mg oral tablet label shows the product name and strength prominently with a pink tablet image imprinted '785'. The label indicates a 100 tablet count, manufactured by Cadila Healthcare Ltd. and distributed by Zydus Pharmaceuticals USA Inc. Additional storage and dosage instructions are noted on the right side.*

FDA Label Image

Container Label (8 mg)

Label for Doxazosin Tablets, USP 8 mg oral tablets by Zydus Pharmaceuticals USA Inc. The label includes an image of a round, pink tablet scored with '766', a barcode, and states the package contains 100 tablets for prescription use only. Manufacturer and distributor information is provided along with storage instructions and dosage reference.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.